Fisher & Paykel Healthcare (ASX:FPH) 3-Year EBITDA Growth Rate : -23.30% (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Fisher & Paykel Healthcare 3-Year EBITDA Growth Rate?

Fisher & Paykel Healthcare's EBITDA per Share for the six months ended in Sep. 2024 was A$0.44.

During the past 12 months, Fisher & Paykel Healthcare's average EBITDA Per Share Growth Rate was -6.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -23.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 0.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Fisher & Paykel Healthcare was 51.70% per year. The lowest was -23.30% per year. And the median was 10.70% per year.

Competitive Comparison of Fisher & Paykel Healthcare's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fisher & Paykel Healthcare's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's 3-Year EBITDA Growth Rate falls into.

Fisher & Paykel Healthcare 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Fisher & Paykel Healthcare (ASX:FPH) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Fisher & Paykel Healthcare 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

FSPKF:USA FPH:New Zealand FPLB:Germany FPLB:Germany

Address

15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013

Website

https://www.fphcare.com

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.